Evidence map›Paper›PMID 35808463›Full record

ArticleSensors (Basel, Switzerland)2022

On the Automatic Detection and Classification of Skin Cancer Using Deep Transfer Learning.

Mohammad Fraiwan, Esraa Faouri

Abstract read
In one paragraph

Article in Sensors (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Alginate Nanoparticles ContainingInternational journal of biomaterials · 2024
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Mohammad FraiwanDepartment of Computer Engineering, Jordan University of Science and Technology, Irbid 22110, Jordan.ORCID 0000-0001-6352-5275
Esraa FaouriDepartment of Computer Engineering, Jordan University of Science and Technology, Irbid 22110, Jordan.ORCID 0000-0002-9674-333X

Funding

Jordan University of Science and Technology 20210047
6 · The paper itself

Abstract

Skin cancer (melanoma and non-melanoma) is one of the most common cancer types and leads to hundreds of thousands of yearly deaths worldwide. It manifests itself through abnormal growth of skin cells. Early diagnosis drastically increases the chances of recovery. Moreover, it may render surgical, radiographic, or chemical therapies unnecessary or lessen their overall usage. Thus, healthcare costs can be reduced. The process of diagnosing skin cancer starts with dermoscopy, which inspects the general shape, size, and color characteristics of skin lesions, and suspected lesions undergo further sampling and lab tests for confirmation. Image-based diagnosis has undergone great advances recently due to the rise of deep learning artificial intelligence. The work in this paper examines the applicability of raw deep transfer learning in classifying images of skin lesions into seven possible categories. Using the HAM1000 dataset of dermoscopy images, a system that accepts these images as input without explicit feature extraction or preprocessing was developed using 13 deep transfer learning models. Extensive evaluation revealed the advantages and shortcomings of such a method. Although some cancer types were correctly classified with high accuracy, the imbalance of the dataset, the small number of images in some categories, and the large number of classes reduced the best overall accuracy to 82.9%.

Indexed as

Skin DiseasesSkin NeoplasmsAlgorithmsArtificial IntelligenceDermoscopyHumansMachine Learningdeep learningimage classificationmelanomaskin cancerskin lesions

Identifiers

PMID35808463
PMCPMC9269808

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.